Post-earnings recap
Reported
Mon, May 4, 2026
EPS actual
$1.23
EPS est.
$1.21
EPS surprise
+1.57%
1-day move
-1.30%
National Health Investors reported better-than-expected earnings per share, which indicates strong performance in that area. However, the stock fell by 1.3% following the earnings release, suggesting that investors may have been disappointed by the lack of revenue information or guidance. The absence of management commentary could also contribute to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.23 | $0.86 | +1.57% |
| Revenue | N/A | $105M | N/A |
No transcript is on record, and the analysis is based on numerical results only.
National Health Investors, Inc. (NHI) is a real estate investment trust (REIT) focused on the healthcare sector. It primarily invests in senior housing and medical properties, which are crucial as the population ages and healthcare needs grow.
Last quarter
In Q4-2025, NHI reported an EPS of $1.22, slightly missing the estimate of $1.24. The stock reacted negatively, dropping 0.51% the following day.
EPS beat streak
0Q
EPS beat rate
50%
Avg EPS surprise
-0.59%
Avg 1-day reaction
-0.39%
Analysts expect NHI to report an EPS of $0.86 and revenue of $105 million for Q1-2026. The market is watching closely for any signs of recovery after recent earnings misses.
Bull case
If NHI beats EPS estimates, it could signal improved operational efficiency and a rebound in demand for healthcare properties, potentially driving the stock higher.
Bear case
Conversely, if NHI misses expectations again, it may raise concerns about the sustainability of its business model and lead to further stock declines.
Key metrics to watch
EPS
0.86Earnings per share is a key indicator of profitability and will show how well the company is managing its investments.
Revenue
105MTotal revenue is important to assess the overall growth and stability of the company's income streams.
The print will turn on these.
Q1
Will NHI's EPS exceed the consensus estimate of $0.86?
A beat on EPS could indicate stronger-than-expected performance and boost investor confidence.
Q2
What factors contributed to revenue expectations of $105 million?
Understanding revenue drivers will help assess the company's growth potential and market position.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The consensus may underestimate the potential for NHI to recover from previous earnings misses, especially if there are signs of increased demand in the healthcare sector.
Supporting evidence
NHI has historically beaten EPS estimates 63% of the time, suggesting potential for a positive surprise.
Options pricing indicates a higher expected move than historical averages, hinting at market anticipation for significant news.
Key risk
If NHI reports strong demand metrics or operational improvements, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is focused on whether NHI can turn around its recent performance and meet or exceed expectations.
Bull confirmed if
An EPS of $0.90 or higher would confirm the bull case and suggest a recovery in operational performance.
Bear confirmed if
An EPS below $0.79 would support the bear case, indicating ongoing challenges in the business.
What the market is pricing for the move.
Implied Move
±3.33%
Historical Avg
±0.9%
The options market is pricing in a potential move of about 3.33%, suggesting that traders expect some volatility around the earnings report.
Options are pricing ±3.3% while NHI has averaged ±0.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
30.6%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If NHI beats expectations, history suggests the stock could rise by about 0.42%, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline of around 0.19%, reflecting ongoing concerns about the company's performance.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Net buying
Recent Transactions
Traded Jul 10, 2026 · disclosed Sep 4, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.